CREATE DATABASE  IF NOT EXISTS `thepharmapill` /*!40100 DEFAULT CHARACTER SET utf8 */;
USE `thepharmapill`;
-- MySQL dump 10.13  Distrib 5.7.9, for Win64 (x86_64)
--
-- Host: localhost    Database: thepharmapill
-- ------------------------------------------------------
-- Server version	5.7.9-log

/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8 */;
/*!40103 SET @OLD_TIME_ZONE=@@TIME_ZONE */;
/*!40103 SET TIME_ZONE='+00:00' */;
/*!40014 SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0 */;
/*!40014 SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, FOREIGN_KEY_CHECKS=0 */;
/*!40101 SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='NO_AUTO_VALUE_ON_ZERO' */;
/*!40111 SET @OLD_SQL_NOTES=@@SQL_NOTES, SQL_NOTES=0 */;

--
-- Table structure for table `brandnameinphtable`
--

DROP TABLE IF EXISTS `brandnameinphtable`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `brandnameinphtable` (
  `drugname` varchar(255) NOT NULL,
  `brandnameintheph` text
) ENGINE=InnoDB DEFAULT CHARSET=utf8;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `brandnameinphtable`
--

LOCK TABLES `brandnameinphtable` WRITE;
/*!40000 ALTER TABLE `brandnameinphtable` DISABLE KEYS */;
/*!40000 ALTER TABLE `brandnameinphtable` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `drugs`
--

DROP TABLE IF EXISTS `drugs`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `drugs` (
  `drugfor` text NOT NULL,
  `drugclassification` text NOT NULL,
  `drugname` varchar(255) NOT NULL,
  `indication` text,
  `contraindication` text,
  `specialprecautions` text,
  `sideeffects` text,
  `druginteraction` text,
  `dosinginformationtype` text,
  `dosinginformation` text,
  `drugsavailableinph` text
) ENGINE=InnoDB DEFAULT CHARSET=utf8;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `drugs`
--

LOCK TABLES `drugs` WRITE;
/*!40000 ALTER TABLE `drugs` DISABLE KEYS */;
INSERT INTO `drugs` VALUES ('Cough','Mucolytics','Acetylcysteine','n/a','Contraindicated w/ some metals (e.g. Fe, copper), rubber, oxygen and oxidising substances, some antimicrobials (e.g. amphotericin B, ampicillin Na, erythromycin lactobionate) and some tetracyclines.','Patient w/ asthma or history of bronchospasm, history of peptic ulcer disease. Pregnancy and lactation.','Bronchospasm, angioedema, rash, pruritus, hypotension, HTN, flushing, nausea, vomiting, fever, syncope, sweating, arthralgia, blurred vision, liver function disturbances, acidosis, convulsion, cardiac or resp arrest; haemoptysis, rhinorrhoea, stomatitis (inhalation); itching, irritation, redness (ophth).','n/a','Oral/Inhalation/Respiratory','Oral\r\nAdult: As loz, granules or effervescent tab: 600 mg daily as a single or in 3 divided doses.\r\nChild: 1 mth to <2 yr 100 mg bid; 2-7 yr 200 mg bid; >7 yr Same as adult dose.\r\nInhalation/Respiratory\r\nAdult: As 10% soln: 6-10 mL 3-4 times daily, may increase to 2-20 mL 2-6 hrly as necessary. As 20% soln: 3-5 mL 3-4 times daily, may increase to 1-10 mL 2-6 hrly as necessary.\r\nChild: Same as adult dose.\r\n','n/a'),('Cough','Mucolytics','Ambroxol HCl','- mucolytic in productive cough and in chronic bronchitis or chronic obstructive pulmonary \r\ndisease (COPD)\r\n','Known hypersensitivity to ambroxol HCl or to any of the excipients of the Ambrotor','Since mucolytics may disrupt the gastric mucosal barrier, ambroxol should be used with care in patients with a history of peptic ulcer disease. Care is also advisable in asthmatic patients. Clearance of ambroxol or its metabolites may be reduced in patients with severe hepatic or renal impairment.','- gastrointestinal adverse effects \r\n- transient rise in serum aminotransferase values \r\n- bronchospasm\r\n- headache	\r\n- dizziness\r\n- sweating\r\n- skin rashes\r\n','n/a','','Adult: 	60-120 mg daily 2-3 divided doses\r\nChildren:\r\n<2 yr		7.5 mg twice a day\r\n2-5 yrs	7.5 mg twice a day/three times a day\r\n6-12 yrs  	15 mg twice a day/three times a day\r\n','Ambrodil, Ambrotor, Broxan, Expel/Expel OD, Medibron, Mucosolvan, Mucusurf, Myracof, Relicof, Strepsils, Tempracof, Voxoll SR, Ambrolex/Ambrolex OD, Bromacef, Broxifil, Mucoangin, Mucovis, Mukex, Phlemasol, RiteMED Ambroxol, Sybron/Sybron Injection, Venteze, Zobrixol©'),('Cough','Mucolytics','Bromhexine HCl','Secretolytic therapy in acute & chronic bronchopulmonary disease associated with abnormal mucus secretion & impaired mucus transport','Patients known to be hypersensitive to bromhexine or other components of Bisolvon.  Bisolvon should not be used in children.','Use in pregnancy & lactation: available preclinical studies as well as clinical experience to date have shown no evidence of ill-effects during pregnancy. Nonetheless, the usual precautions regarding the use of drugs during pregnancy, especially during the first trimester, should be observed. Bisolvon is expected to enter breast milk and thus should be avoided in lactation','Generally well tolerated. Reports of side effects:\r\n-	mild gastrointestinal\r\n-	allergic reactions (skin rashes)\r\n-	bronchospasm\r\n-	angioedema\r\n-	anaphylaxis (rare)\r\n','Administration of bromhexine together with antibiotics (amoxicillin, cefuroxime, erythromycin, doxycycline) leads to higher antibiotic concentration in the lung tissue. No clinically relevant unfavorable interaction with other medications have been reported.','Tablet/Oral/Caapsule/Inhalation/Syrup/Ampoule','TABLET:\r\nAdult: 		8 mg (1 tab) three times a day\r\nChildren:\r\n2-6 yrs		4 mg (1/2 tab) twice a day\r\n6-12 yrs  		4 mg (1/2 tab) three times a day\r\n>12 yrs		8 mg (1 tab) three times a day\r\nCAPSULE:\r\nAdult: 		1 capsule three times a day\r\nORAL SOLUTION:\r\nAdult: 		4 mL three times a day\r\nChildren:\r\n<2 yrs			10 drops three times a day\r\n   2-6 yrs		20 drops three times a day								6-12 yrs  		2 mL three times a day\r\n	>12 yrs		4 mL three times a day\r\n\r\nINHALATION SOLUTION\r\nAdult: 		4 mL twice a day\r\nChildren:\r\n<2 yrs			5 drops twice a day\r\n2-6 yrs		10 drops twice a day						\r\n6-12 yrs  		1 mL twice a day\r\n>12 yrs		2 mL\r\nSYRUP:\r\nAdult: 		5 mL (1 teaspoon) three times a day\r\nChildren:\r\n>12 yrs	 	5 mL (1 teaspoon) three times a day\r\nAMPOULE – severe cases, before and after surgical intervention\r\n1 amp SC, IM, or IV (duration of injection: 2-3 minutes) 2-3 times daily\r\n','Bisolvon©'),('Colds','Antihistamines','Cetirizine','Allergies','n/a','Epileptic patients and patients at risk of convulsions. Hepatic and renal impairment. Elderly. Pregnancy and lactation.','Somnolence, insomnia, pharyngitis, abdominal pain, coughing, diarrhoea, epistaxis, bronchospasm. \r\nFatigue, dizziness, headache, nausea, vomiting, dry mouth.\r\n','Additive CNS depression when administered concomitantly w/ other CNS depressants (e.g. sedatives, tranquilisers). ','Oral','Oral\r\n\r\nAdult: 10 mg once daily or 5 mg bid.\r\nChild: 6-23 mth 2.5 mg once daily increased to max of 2.5 mg bid in childn ≥12 mth; 2-5 yr 5 mg once daily or in 2 divided doses; ≥6 yr 10 mg once daily or in 2 divided doses.\r\nElderly: Initially, 5 mg once daily.\r\n','Afrovir©, Aletor©, Allerkid©, Allermed©, Allerteen©, Antrazine©, Askey©, Axella©'),('Colds','Antihistamines','Chlorpheniramine','Allergies','Premature infants or neonates.','May impair ability to drive and operate machinery. Avoid alcohol. Angle-closure glaucoma, urinary retention, prostatic hyperplasia or pyloroduodenal obstruction; epilepsy; hepatic impairment. Pregnancy, lactation. Elderly.','Rarely, rashes and hypersensitivity reactions; blood disorders, convulsions, sweating, myalgia, paraesthesias, extrapyramidal effects, tremor, confusion, sleep and GI disturbances, tinnitus, hypotension, hair loss.\r\nCNS depression including slight drowsiness to deep sleep, lassitude, dizziness, incoordination. Headache, psychomotor impairment and antimuscarinic effects.\r\n','Potentiates sedative effect of psychotropic drugs e.g. barbiturates, hypnotics, opioid analgesics, anxiolytics and antipsychotics. Interaction with alcohol could be dangerous (sedation/excitation).','Oral/Parental','Oral\r\nAdult: 4-8 mg 3-4 times daily. Individualize dosage according to patient\'s response and tolerance.\r\nChild: ≤3 yr: 0.4-1 mg/kg/ day, given as 4 divided doses. 3-6 yr: 1-2 mg and 6-12 yr: 2-4 mg, doses to be given 3-4 times daily.\r\n\r\nParenteral\r\nAdult: 10 mg every 8-12 hr. Dose can be given via SC, IM or slow IV inj. Max: 40 mg/24 hr.\r\n','Antamin©, Phil Pharmawealth©'),('Colds','Antihistamines','Clemastine','Allergies','Hypersensitivity','Pregnancy, lactation. Tip of the bottle should be dipped in boiling water, dried and capped appropriately after every use.','Irritation, stinging and itching of the nasal mucosa. \r\nSneezing, nosebleeds, headache; nausea, taste disturbances, somnolence, dry mouth.','Antagonises effects of cholinergic agents and neuroleptics.\r\nPotentially Fatal: Severe sedation and CNS depression may occur when used concomitantly with alcohol or other CNS depressants. \r\n','Nasal','Adult: 140 mcg by nasal spray into each nostril bid.\r\nChild: ≥5 yr: 140 mcg by nasal spray into each nostril bid.\r\n','Marsthine©'),('Colds','Antihistamine + Nasal Decongestants','Dexbrompheniramine + Pseudoephedrine','Allergies','Severe liver disease; premature infants or full-term neonates.','Pregnancy; lactation; severe CV disorders; asthma; avoid alcohol; drowsiness; angle-closure glaucoma, urinary retention, prostatic hypertrophy, pyloroduodenal obstruction; renal and hepatic impairment; elderly; epilepsy.','Occasionally, paradoxical CNS stimulation; psychomotor impairment; headache; palpitations and arrhythmias; convulsions, sweating, myalgia, paraesthesias, extrapyramidal symptoms, tremor; sleep and GI disturbances; hypersensitivity reactions and blood disorders; tinnitus, hypotension; hair loss. Withdrawal symptoms following long-term therapy.\r\n\r\nSedation; antimuscarinic effects, CNS depression and disturbances;\r\n','Increased BP with other sympathomimetic agents (e.g. decongestants, TCA, appetite suppressants). Reduced hypotensive effects of methyldopa, α- and β-adrenergic blockers. Increased side effects (e.g. somnolence, agitation) with atomoxetine.\r\nPotentially Fatal: Increased risk of hypertensive crisis with furazolidine, avoid concurrent use. Increased risk of hypertensive crisis with MAOIs; avoid concurrent use or within 2 wk after stopping MAOIs. Increased risk of psychosis with bromocriptine. \r\n','Oral','Adult: In combination with decongestant, pseudoephedrine: 2 mg up to 4 times daily.\r\nChild: >6 yr: In combination with pseudoephedrine, 1 mg up to 4 times daily.\r\n','N/A'),('Colds','Antihistamines','Diphenhydramine','Allergies','Asthma, narrow angle glaucoma, prostatic hypertrophy, stenosing peptic ulcer, pyloroduodenal obstruction or bladder neck obstruction, porphyria. Neonates or premature infants. Lactation','Patient w/ glaucoma, urinary retention, myasthenia gravis, epilepsy or seizure disorders, bronchitis or COPD, CV disease, thyroid dysfunction. Hepatic and moderate to severe renal impairment. Pregnancy.','Menstrual disease; GI disturbances (e.g. anorexia, constipation, diarrhoea); difficulty in micturition, urinary frequency, urinary retention; agranulocytosis, haemolytic anaemia, thrombocytopenia; anaphylactic shock; tremor; blurred vision, diplopia; acute labyrinthitis, tinnitus; constriction of pharynx, nasal congestion, thickening of bronchial secretions, wheezing; photosensitivity, rash, urticaria (topical).\r\nChest tightness, extrasystoles, hypotension, palpitations, tachycardia; ataxia, chills, confusion, dizziness, drowsiness, euphoria, excitement, fatigue, headache, insomnia, irritability, nervousness, neuritis, paraesthesia, paradoxical excitation, restlessness, sedation, seizure, vertigo; diaphoresis;\r\n','Additive effect w/ other CNS depressants (e.g. hypnotics, sedatives, tranquilisers, TCAs). Prolonged and increased anticholinergic effects w/ MAOIs. May potentiate the effect of anticholinergic drugs (e.g. atropine). ','Oral/Parental','Oral\r\nAdult: 25-50 mg 3-4 times daily. For prevention of motion sickness, admin 30 min before exposure to motion. Max: 300 mg daily.\r\nChild: 2 to <6 yr 6.25 mg 4-6 hrly; 6-12 yr 12.5-25 mg 4-6 hrly. For prevention of motion sickness, admin 30 min before exposure to motion.\r\n\r\nParenteral\r\nAdult: As 1% or 5% soln: 10-50 mg by deep IM or IV inj, up to 100 mg may be used if needed. Max: 400 mg daily.\r\nChild: 5 mg/kg daily in 4 divided doses by deep IM or IV inj. Max: 300 mg daily.\r\n','Benadrex©, Benadryl©, Benaxil©, Bexil©, Hydrazol©, Hyphen©, RiteMED Diphenhydramine©'),('Colds','Antihistamines','Loratadine ','Allergies','n/a','- Hepatic and renal impairment.\r\n- Elderly. \r\n- Pregnancy and lactation.\r\n','Headache, drowsiness, fatigue, sedation, nervousness, hyperkinesia, dysphonia, malaise, wheezing, upper resp tract infection, dry mouth, epistaxis, pharyngitis, abdominal pain, diarrhoea, stomatitis, tooth disorder, conjunctivitis, earache, influenza-like symptoms, viral infections and rash.\r\nRarely, peripheral oedema, jaundice, hepatitis, hepatic necrosis, anaphylaxis and erythema multiforme. \r\n','May increase plasma concentrations w/ inhibitors of CYP3A4 and/or CYP2D6 (e.g. cimetidine, erythromycin, ketoconazole, clarithromycin, quinidine, fluconazole, fluoxetine). ','Oral','Oral\r\nAdult: 10 mg once daily or 5 mg 12 hrly.\r\nChild: 2-5 yr 5 mg once daily; ≥6 yr Usual adult dose.\r\n','Allerta©, Claritin©, Lorange©, Lorano©, Loratyne©, Lorfast©, Lorid©, Ratalin©, RiteMED Loratadine©, Zylohist©'),('Colds','Nasal Decongestants','Oxymetazoline','Nasal congestion','Glaucoma; hyperthyroidism, heart disease (including angina), hypertension, advanced arteriosclerotic conditions. Children <6 yr.','Pregnancy, lactation. Difficulty in urination secondary to prostate enlargement; DM.','Prolonged or frequent use of nasal drops or spray may cause rebound congestion. Headache, insomnia, tachycardia, hypertension, nervousness, nausea, dizziness, palpitation, arrhythmia. \r\nNasal drops or spray: Local stinging or burning, sneezing, dryness of mouth and throat.\r\n','Potentially Fatal: Hypertensive crisis with MAOIs. ','Nasal','Adult: As 0.05% solution: Spray 1-3 times into each nostril bid.\r\nChild: ≥6 yr: Instill or spray 0.05% solution 1-3 times into each nostril bid.\r\n','Drixine©, Nasofree©, Nasofix©'),('Colds','Nasal Decongestants','Phenylephrine ','Nasal congestion','- Hypertension, ventricular tachycardia. \r\n- Oral: use with or within 14 days of MAOI therapy. \r\n- Ophthalmic: narrow-angle glaucoma.\r\n','Severe hyperthyroidism, severe ischaemic heart disease, DM, prostatic hyperplasia. \r\nRebound congestion in prolonged or excessive use of nasal drops. \r\nUse 10% eye drops in extreme caution in infants, elderly, cardiac disease, significant hypertension, advanced arteriosclerosis. \r\nPregnancy and lactation. \r\nOver-the-counter cough and cold medications should not be used in infants and children <2 yr.\r\n','Anxiety, reflex bradycardia, tachycardia, arrhythmias, headache, cold extremities/gangrene, hypertension, nausea, vomiting, sweating, weakness, fear, restlessness, insomnia, confusion, irritability, psychotic states, dyspnoea, anorexia, palpitations, extravasation causing tissue necrosis and sloughing, mydriasis, difficulty in micturition and urinary retention, piloerection, increased salivation, hyperglycaemia, lactic acidosis. Ophthalmic solutions may liberate pigment granules from the iris, corneal clouding/damage. \r\nPotentially Fatal: Increase in cardiac contractility, which may lead to angina or cardiac arrest; severe hypertension leading to cerebral haemorrhage or pulmonary oedema. \r\n','May increase hypertensive effect of beta-blockers (nonselective); MAOI potentiate hypertension; methyldopa and TCA can increase the pressor response.','Oral/Nasal','Oral\r\nAdult: As hydrochloride: 10 mg every 4 hr, max 60 mg daily; or 12 mg up to 4 times daily.\r\nChild: Child: 2-6 yr: As tannate salt: 1.87-3.75 mg every 12 hr. 6-12 yr: As hydrochloride salt: 10 mg every 4 hr; as tannate salt: 3.75-7.5 mg every 12 hr. >12 yr: As hydrochloride salt: 10-20 mg every 4 hr; as tannate salt: 7.5-15 mg every 12 hr.\r\n\r\nNasal\r\nAdult: 0.25 to 1% solution: Instill as nasal drops or a spray into each nostril every 4 hr as needed.\r\nChild: 2-6 yr: 0.125% or 0.16% solution: 2-3 drops into each nostril every 4 hr as needed; 6-12 yr: 0.25% solution: 2-3 drops, or 1-2 sprays, into each nostril every 4 hr as needed.\r\nDrug Interactions: May increase hypertensive effect of beta-blockers (nonselective); MAOI potentiate hypertension; methyldopa and TCA can increase the pressor response.\r\n','Mydfrin'),('Colds','Antihistamine + Nasal Decongestants','Triprolidine + Pseudoephedrine','Allergic rhinitis, Cold and flu','Concurrent use or within 2 wk of stopping MAOIs. Severe hypertension or coronary artery disease.','Severe hepatic impairment. Moderate to severe renal impairment. DM, hyperthyroidism, increased intraocular pressure, prostatic hypertrophy, hypertension, heart disease. May affect ability to drive or operate machinery. Pregnancy and lactation.','Rarely, hallucinations.\r\n\r\nDry mouth, nose and throat; skin rashes, tachycardia, drowsiness, sleep disturbances, urinary retention.\r\n','Increased BP with other sympathomimetic agents (e.g. decongestants, TCA, appetite suppressants). Reduced hypotensive effects of methyldopa, α- and β-adrenergic blockers. Increased side effects (e.g. somnolence, agitation) with atomoxetine.\r\nPotentially Fatal: Increased risk of hypertensive crisis with furazolidine, avoid concurrent use. Increased risk of hypertensive crisis with MAOIs; avoid concurrent use or within 2 wk after stopping MAOIs. Increased risk of psychosis with bromocriptine.\r\n','Oral','Oral\r\nAdult: Each tablet contains triprolidine HCl 2.5 mg and pseudoephedrine HCl 60 mg: 1 tablet 4-6 hrly, up to 4 times a day. As syrup containing triprolidine HCl 1.25 mg and pseudoephedrine HCl 30 mg/5 ml: 10 ml 4-6 hrly, up to 4 times daily.\r\nChild: Each tablet contains triprolidine HCl 2.5 mg and pseudoephedrine HCl 60 mg: > 12 yr: 1 tablet 4-6 hrly, up to 4 times a day. As syrup containing triprolidine HCl 1.25 mg and pseudoephedrine HCl 30 mg/5 ml: 6-12 yr: 5 ml 4-6 hrly, up to 4 times daily. 2-5 yr: 2.5 ml 4-6 hrly, up to 4 times daily; may be diluted 1:1-1:4 with syrup BP.\r\n','Fedac©'),('Colds','Nasal Decongestants','Xylometazoline','Nasal congestion','Glaucoma; hyperthyroidism, heart disease (including angina), hypertension, advanced arteriosclerotic conditions. Children <6 yr.','Pregnancy, lactation. Difficulty in urination secondary to prostate enlargement; DM.','Prolonged or frequent use of nasal drops or spray may cause rebound congestion. Headache, insomnia, tachycardia, hypertension, nervousness, nausea, dizziness, palpitation, arrhythmia. \r\nNasal drops or spray: Local stinging or burning, sneezing, dryness of mouth and throat.\r\n','Increased heart rate or BP with sibutramine.\r\nPotentially Fatal: Hypertensive crisis with MAOIs. \r\n','Nasal','Adult: As 0.05% solution: Spray 1-3 times into each nostril bid.\r\nChild: ≥6 yr: Instill or spray 0.05% solution 1-3 times into each nostril bid.\r\n','Xylone'),('Hypertension','Diuretic','Furosimide','','','','','','','','Lasix'),('Fever','Analgesic/Antipyretics','Aspirin','•	Prophylaxis of thromboemobolic disorders in preventing myocardial infarction and transient ischemic attacks. \r\n•	Provides quick relief of headache, rheumatism, muscular pains, toothache, neuralgia, periodic pains\r\n•	Reduces fever and discomforts in colds and flu. \r\n','- History of salicylate-induced asthma.\r\n- Active peptic ulcers\r\n- Hemorrhagic diathesis\r\n- severe renal or cardiac failure\r\n- Combination with methotrexate at doses of > or = 15mg/week\r\n','- Renal disorders\r\n- G6PD deficiency\r\n- Patients with flu, chicken pox, or hemorrhagic fever, GI ulceration or asthma\r\n- Pregnant women close to delivery.\r\n','- Renal disorders\r\n- G6PD deficiency\r\n- Patients with flu, chicken pox, or hemorrhagic fever, GI ulceration or asthma\r\n- Pregnant women close to delivery.\r\n','- Methotrexate\r\n- Anticoagulants\r\n- Thrombolytics and other anti platelets\r\n- Uricosuric drugs\r\n- Digoxin\r\n- Antidiabetics\r\n- Diuretics\r\n- systemic glucocorticoids EXCEPT Hydrocortisone\r\n- ACE inhibitors\r\n- Valproic acid\r\n- Alcohol\r\n','Taken With Food','(TAKEN WITH FOOD)\r\nADULT\r\n- 100mg tab (Prophylaxis of thromboembolic disorders) 1 tab daily\r\n- 300mg tab (Pain) 1 to 2 tabs. Repeat after 3 to 4 hours, as needed. \r\nCHILDREN \r\n- (>5y/o) 1 tablet\r\n- (3 to 5 y/o) 1/2 tablet\r\n***Repeat if necessary BUT is not taken >3 times daily.\r\n','Bayer©'),('Fever','Analgesic/Antipyretics','Paracetamol','•	Mild to moderate pain and fever.','n/a','•	Patient with chronic alcoholism, known G6PD deficiency, severe hypovolemia, chronic malnutrition.\r\n•	Renal and hepatic impairment. \r\n•	Pregnancy and lactation\r\n','- Thrombocytopenia\r\n- Leucopenia\r\n- Pancytopenia\r\n- Neutropenia\r\n- Agranulocytosis\r\n- Pain and burning sensation at injection site\r\n- RARE: Hypotension and Tachycardia\r\n','- May reduce serum levels with anticonvulsants (ex. phenytoin, barbiturates, carbamazepine). \r\n- May enhance anticoagulant effect of warfarin and other coumarins with prolonged use.\r\n- Accelerated absorption with metoclopramide and domperidone.\r\n- May increase serum levels with probenecid.\r\n- May increase serum levels of chloramphenicol.\r\n- May reduce absorption with colestyramine within 1 hour of administration.\r\n- May cause severe hypothermia with phenothiazine.\r\n','','(MAY BE TAKEN WITH OR WITHOUT FOOD)\r\nOral Prep:\r\nADULT\r\n0.5-1g taken every 4 to 6 hours.\r\nMAX: 4g/day\r\nCHILDREN\r\nGiven every 4 to 6 hours, if necessary.\r\nMAX DOSE: 4 doses in 24 hours.\r\n3 to <6 months: 60mg\r\n6 months to 2 years: 120mg\r\n2 to <4 y/o: 180mg\r\n4 to <6 y/o: 240mg or 250mg\r\n8 to 10 y/o: 360mg or 375mg\r\n10 to <12 y/o: 480mg or 500mg\r\n12 to 16 y/o: 480 or 750mg\r\nRectal Suppository:\r\nADULT\r\n0.5-1g given every 4 to 6 hours.\r\nMAX: 4g/day\r\nCHILDREN\r\nGiven every 4 to 6 hours, if necessary.\r\n3 months to <1 y/o: 60mg to 125mg\r\n1 to <5y/o: 125mg to 250mg\r\n5 to 12y/o: 250mg to 500mg\r\n=Intravenous=\r\nADULT\r\n33-50kg: 15mg/kg as a single dose, every 4 hours\r\nMAX: 60mg/kg/day up to 3g/day\r\n>50kg: 1g as a single dose, at least every 4 hours\r\nMAX: 4g/day.\r\nCHILDREN\r\n<10kg: 7.5mg/kg as a single dose, at least every 4 hours\r\nMAX: 30mg/kg/daily\r\n10-33kg: 15mg/kg as a single dose, every 4 hours.\r\nMAX: 60mg/kg up to 2g/day\r\n>33-50kg: 15mg/kg as a single dose at least every 4 hours\r\nMAX: 60mg/kg up to 3g/day\r\n**Administer by infusion over 15 minutes. \r\n','Biogesic©, Tempra©, Calpol©, Aeknil©'),('Fever','Analgesic/Antipyretics','Ibuprofen','•	Management of mild to moderate pain and inflammation in conditions (ex. dysmenorrhea, headache including migraine, post-op and dental pain, musculoskeletal and joint disorders (ex. ankylosing spondylitis, osteoarthritis and rheumatoid arthritis including juvenile idiopathic arthritis, peri-articular disorders (ex. bursitis and tenosynovitis and soft tissue disorders (ex. sprains and strains).\r\n•	Reduction of fever.\r\n','- Hypersensitivity to aspirin or to other NSAIDs.\r\n- Concurrent or previous history of GI ulcer or bleeding.\r\n- Last trimester of pregnancy.\r\n','- Do not take >10days for pain OR >3 days for fever OR when severe allergic reaction including skin reddening, rash or blisters develops.\r\n- Discontinue use if pain or fever persists or gets worse, painful area is red or swollen, bloody vomit or stool.\r\n- Asthma\r\n- Heart or kidney disease\r\n- Liver cirrhosis\r\n- Hypertension\r\n- Concomitant use with other NSAIDs (ex. aspirin, acetaminophen).\r\n- May increase risk of heart attack or stroke on long-term use.\r\n- Pregnancy and lactation.\r\n- Children <12 y/o.\r\n- Elderly.\r\n','- Abdominal pain\r\n- Diarrhea\r\n- Nausea with or without vomiting\r\n- GI bleeding\r\n- Ulceration\r\n','- Other NSAIDs\r\n- Anticoagulants\r\n- Increased risk of GI bleeding with SSRIs.\r\n- Increased plasma concentration of lithium.\r\n','Taken With Food','(TAKEN WITH FOOD)\r\nSoftgel:\r\nADULT\r\n- 200 to 400mg every 4 to 6 hours.\r\nMAX: 1200mg/day.\r\n','Advil©'),('Fever','Analgesic/Antipyretics','Naproxen ','•	Musculoskeletal and joint disorders (ex. anklosing spondylitis, osteoarthritis, rheumatoid arthritis including juvenile idiopathic arthritis.\r\n•	Dysmenorrhea\r\n•	Headache including migraine\r\n•	Post-op pain\r\n•	Soft tissue disorders\r\n•	Acute gout\r\n•	Reduce fever\r\n','- Hypersensitivity to naproxen, ASA or any other NSAIDs.\r\n- Stroke (CVA)\r\n- Heart attack (MI)\r\n- CABG\r\n- Uncontrolled hypertension\r\n- CHF (NYHA II-IV).\r\n- Active peptic ulceration\r\n- Pregnancy\r\n','- Patients with cardiac, liver, and renal diseases/impairment\r\n- Infection, asthma, allergic and hemorrhagic disorders\r\n- History of peptic ulceration\r\n- Monitor for development of blood, kidney, or eye disorders.\r\n- May interfere with thyroid function test\r\n- Elderly.\r\n','- GI discomfort\r\n- Nausea\r\n- Diarrhea\r\n- Headache\r\n- Vertigo\r\n- Dizziness\r\n- Nervousness\r\n- Tinnitus\r\n- Depression\r\n- Drowsiness\r\n- Insomnia\r\n- Anemia\r\n- Thrombocytopenia\r\n- Neutropenia\r\n- Eosinophilia\r\n- Agranulocytosis\r\n- Nephrotoxicity\r\n- Hematuria\r\n','- Enhanced effects of oral anticoagulants, phenytoin and sulfonylurea anti diabetics.\r\n- Increased plasma concentration of lithium, methotrexate and cardiac glycosides.\r\n- Increased risk of nephrotoxicity (w/ ACE inhibitors, cyclosporin, tacrolimus, or diuretics)\r\n- Hyperkalemia (with K-sparing diuretics)\r\n- GI bleeding/ulceration (w/ corticosteroid or possibly, alcohol, bisphosphonates or pentoxifylline)\r\n- Hemotoxity (w/ zidovudine).\r\n- Reduced effects of antihypertensives (ex. Beta blockers).\r\n- Risk of convulsion with quinolones.\r\n- Enhanced effect by moclobemide.\r\n- Other NSAIDs including aspirin.\r\n- Increased plasma concentration with probenecid.\r\n','Taken With Food','(TAKEN WITH FOOD)\r\nRheumatic disorders:\r\n550mg to 1100mg daily as single or in 2 divided doses\r\nAcute gout:\r\nInitially 550mg followed by 275mg every 6 to 8 hours.\r\nMAX: 1375mg/day after the 1st day.\r\nJuvenile idiopathic arthritis:\r\nCHILDREN\r\n>5 y/o: 11mg/kg body weight daily in 2 divided doses\r\n','Pharex©'),('Fever','Analgesic/Antipyretics','Ketoprofen','•	For Rheumatic disorders, pain and inflammation, pain and inflammation associated with musculoskeletal and joint disorders, pain following orthopedic surgery, rectal rheumatic disorders, and topical pain relief. Fever reducer.','- For all routes: Hypersensitivity to aspirin or other NSAIDs or those suffering from asthma, angioedema, urticaria, or rhinitis. \r\n- Active GI disease (ex. bleeding or ulcer)\r\n- Severe heart failure and renal insufficiency\r\n- Treatment of preoperative pain in the setting CABG surgery.\r\n- Patients with history of proctitis or haemorrhoids\r\n','- History of GI disease (ex. bleeding or ulcer).\r\n- Hypertensive patients\r\n- Renal or hepatic impairment\r\n- Pregnancy and lactation\r\n- Elderly.\r\n','- Hypertension\r\n- GI symptoms (ex. dyspepsia, discomfort, nausea, diarrhoea)\r\n- Pain and tissue damage at injection site (IM)\r\n- Cardiovascular toxicity (chest pain, dyspnea, weakness, slurred speech)\r\n- May mask the usual signs and symptoms of infection.\r\n- NSAID-induced liver dysfunction\r\n- Anaphylactoid reaction (ex. difficulty breathing, swelling of the face or throat)\r\n- Photosensitivity reactions (topical)\r\n- Potentially fatal: Anaphylaxis, exfoliative dermatitis, Steven-Johnson syndrome, toxic epidermal necrolysis\r\n','- Increases plasma concentrations of lithium and methotrexate.\r\n- Reduces effects of antihypertensives (ex. ACE inhibitors, angiotensin II receptor antagonists).\r\n- Increased risk of GI bleeding with warfarin.\r\n- Decreased protein binding of ketoprofen and increased risk for serious GI events with aspirin and other NSAIDs.\r\n- Increased risk of developing renal failure with diuretics.\r\n- Increased risk of GI bleeding and ulceration with corticosteroids.\r\n- Increased plasma levels with probenecid.\r\n- Salicylate reduces conjugation and renal elimination of ketoprofen.\r\n','Taken With Food','(TAKEN WITH FOOD)\r\nIM:\r\nPain and inflammation associated with musculoskeletal and joint disorders, pain following orthopedic surgery: \r\nADULT \r\n50-100mg by deep injection into the gluteal muscle every 4 hours.\r\nMAX: 200mg in 24 hours for up to 3 days.\r\nOral:\r\nRheumatic disorders:\r\nADULT\r\n100-200mg/day in 2 to 4 divided doses.\r\nMAX: 300mg/day in divided doses. As modified-release formulation: Administer dose once daily.\r\nELDERLY\r\n>75 y/o: Reduce initial dose.\r\nTopical/Cutaneous:\r\nLocal Pain relief:\r\nADULT\r\nAs 2.5% gel: Apply onto affected areas 2-4 times daily for up to 10 days.\r\nAs 30mg plaster: Apply 1 plaster twice daily.\r\n','Pharex©');
/*!40000 ALTER TABLE `drugs` ENABLE KEYS */;
UNLOCK TABLES;
/*!40103 SET TIME_ZONE=@OLD_TIME_ZONE */;

/*!40101 SET SQL_MODE=@OLD_SQL_MODE */;
/*!40014 SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS */;
/*!40014 SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS */;
/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
/*!40111 SET SQL_NOTES=@OLD_SQL_NOTES */;

-- Dump completed on 2016-11-29 20:36:49
